Latest Insider Transactions at Imara Inc. (IMRA)
This section provides a real-time view of insider transactions for Imara Inc. (IMRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IMARA Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IMARA Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 28
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,250
-94.8%
|
$175,000
$28.8 P/Share
|
|
Oct 28
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+50.0%
|
$12,500
$2.48 P/Share
|
|
Oct 18
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
814
-100.0%
|
$24,420
$30.0 P/Share
|
|
Oct 18
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
814
+50.0%
|
$1,628
$2.48 P/Share
|
|
Oct 18
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
924
-0.09%
|
$27,720
$30.0 P/Share
|
|
Oct 18
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
847
-0.08%
|
$25,410
$30.0 P/Share
|
|
Oct 18
2024
|
Anish Patel CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Indirect |
716
-0.21%
|
$21,480
$30.0 P/Share
|
|
Oct 18
2024
|
Helen Louise Collins CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
816
-100.0%
|
$24,480
$30.0 P/Share
|
|
Oct 18
2024
|
Helen Louise Collins CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
816
+50.0%
|
$1,632
$2.48 P/Share
|
|
Oct 18
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Indirect |
753
-2.7%
|
$22,590
$30.0 P/Share
|
|
Oct 18
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
817
-0.66%
|
$24,510
$30.0 P/Share
|
|
Oct 15
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
1,270
-1.01%
|
$34,290
$27.67 P/Share
|
|
Oct 09
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
37,878
-1.8%
|
$1,060,584
$28.32 P/Share
|
|
Oct 09
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
16,710
-0.82%
|
$467,880
$28.3 P/Share
|
|
Oct 08
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
13,267
-0.62%
|
$371,476
$28.24 P/Share
|
|
Oct 08
2024
|
Rahul D. Ballal |
SELL
Open market or private sale
|
Direct |
10,420
-31.81%
|
$291,760
$28.17 P/Share
|
|
Oct 08
2024
|
Rahul D. Ballal |
BUY
Exercise of conversion of derivative security
|
Direct |
10,420
+14.6%
|
$125,040
$12.6 P/Share
|
|
Oct 08
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
13,267
-0.64%
|
$371,476
$28.23 P/Share
|
|
Oct 07
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,270
-100.0%
|
$34,290
$27.51 P/Share
|
|
Oct 07
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,270
+38.84%
|
$2,540
$2.48 P/Share
|
|
Oct 07
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
2,730
-0.26%
|
$73,710
$27.5 P/Share
|
|
Oct 07
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
2,707
-0.25%
|
$73,089
$27.61 P/Share
|
|
Oct 04
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
2,825
-2.2%
|
$76,275
$27.51 P/Share
|
|
Oct 04
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,218
-100.0%
|
$275,886
$27.51 P/Share
|
|
Oct 04
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,218
+50.0%
|
$20,436
$2.48 P/Share
|
|
Oct 04
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
12,206
-1.16%
|
$329,562
$27.51 P/Share
|
|
Oct 04
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
7,522
-0.7%
|
$203,094
$27.51 P/Share
|
|
Oct 01
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
521
-100.0%
|
$14,067
$27.54 P/Share
|
|
Oct 01
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
521
+50.0%
|
$1,042
$2.48 P/Share
|
|
Oct 01
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
526
-0.05%
|
$14,202
$27.54 P/Share
|
|
Oct 01
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
527
-0.05%
|
$14,229
$27.54 P/Share
|
|
Oct 01
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
518
-0.4%
|
$13,986
$27.54 P/Share
|
|
Sep 30
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$50,000
$25.33 P/Share
|
|
Sep 30
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$4,000
$2.48 P/Share
|
|
Sep 27
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,250
-100.0%
|
$102,000
$24.27 P/Share
|
|
Sep 27
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,250
+50.0%
|
$8,500
$2.48 P/Share
|
|
Sep 16
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
1,270
-0.97%
|
$27,940
$22.41 P/Share
|
|
Aug 29
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
12,000
-0.55%
|
$264,000
$22.78 P/Share
|
|
Aug 27
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,250
-100.0%
|
$93,500
$22.54 P/Share
|
|
Aug 27
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,250
+50.0%
|
$8,500
$2.48 P/Share
|
|
Aug 26
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
12,000
-1.13%
|
$264,000
$22.89 P/Share
|
|
Aug 15
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
1,270
-0.48%
|
$29,210
$23.26 P/Share
|
|
Jul 31
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
2,270
-0.21%
|
$61,290
$27.56 P/Share
|
|
Jul 31
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect |
3,099
-0.28%
|
$83,673
$27.56 P/Share
|
|
Jul 31
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Indirect |
649
-2.27%
|
$17,523
$27.5 P/Share
|
|
Jul 31
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
1,702
-1.28%
|
$45,954
$27.51 P/Share
|
|
Jul 31
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
991
-100.0%
|
$26,757
$27.53 P/Share
|
|
Jul 31
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
991
+50.0%
|
$1,982
$2.48 P/Share
|
|
Jul 29
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,250
-99.42%
|
$141,750
$27.06 P/Share
|
|
Jul 29
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,250
+50.0%
|
$10,500
$2.48 P/Share
|